These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1336487)

  • 1. AZT-induced mitochondrial myopathy.
    Tomelleri G; Tonin P; Spadaro M; Tilia G; Orrico D; Barelli A; Bonetti B; Monaco S; Salviati A; Morocutti C
    Ital J Neurol Sci; 1992 Dec; 13(9):723-8. PubMed ID: 1336487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cytochrome c oxidase subunits encoded by mitochondrial or nuclear DNA in the muscle of patients with zidovudine myopathy.
    Chariot P; Bonne G; Authier FJ; Marsac C; Gherardi R
    J Neurol Sci; 1994 Sep; 125(2):190-3. PubMed ID: 7807166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome c oxidase deficiency in the muscle of patients with zidovudine myopathy is segmental and affects both mitochondrial DNA- and nuclear DNA-encoded subunits.
    Yerroum M; Pham-Dang C; Authier FJ; Monnet I; Gherardi R; Chariot P
    Acta Neuropathol; 2000 Jul; 100(1):82-6. PubMed ID: 10912924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome c oxidase deficiency in zidovudine myopathy affects perifascicular muscle fibres and arterial smooth muscle cells.
    Chariot P; Le Maguet F; Authier FJ; Labes D; Poron F; Gherardi R
    Neuropathol Appl Neurobiol; 1995 Dec; 21(6):540-7. PubMed ID: 8745244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of L-carnitine on the zidovudine-induced destruction of human myotubes. Part I: L-carnitine prevents the myotoxicity of AZT in vitro.
    Semino-Mora MC; Leon-Monzon ME; Dalakas MC
    Lab Invest; 1994 Jul; 71(1):102-12. PubMed ID: 7518879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV or zidovudine myopathy?
    Gherardi R; Chariot P
    Neurology; 1994 Feb; 44(2):361-2; author reply 362-4. PubMed ID: 8309597
    [No Abstract]   [Full Text] [Related]  

  • 7. Fatal infantile mitochondrial myopathy and renal dysfunction due to cytochrome-c-oxidase deficiency.
    DiMauro S; Mendell JR; Sahenk Z; Bachman D; Scarpa A; Scofield RM; Reiner C
    Neurology; 1980 Aug; 30(8):795-804. PubMed ID: 6251406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome c oxidase reaction improves histopathological assessment of zidovudine myopathy.
    Chariot P; Monnet I; Gherardi R
    Ann Neurol; 1993 Oct; 34(4):561-5. PubMed ID: 8215243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suramin-induced weakness from hypophosphatemia and mitochondrial myopathy. Association of suramin with mitochondrial toxicity in humans.
    Rago RP; Miles JM; Sufit RL; Spriggs DR; Wilding G
    Cancer; 1994 Apr; 73(7):1954-9. PubMed ID: 8137223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zidovudine causes early increases in mitochondrial ribonucleic acid abundance and induces ultrastructural changes in cultured mouse muscle cells.
    d'Amati G; Lewis W
    Lab Invest; 1994 Dec; 71(6):879-84. PubMed ID: 7528833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zidovudine-induced experimental myopathy: dual mechanism of mitochondrial damage.
    Masini A; Scotti C; Calligaro A; Cazzalini O; Stivala LA; Bianchi L; Giovannini F; Ceccarelli D; Muscatello U; Tomasi A; Vannini V
    J Neurol Sci; 1999 Jul; 166(2):131-40. PubMed ID: 10475107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrastructural characteristics and DNA immunocytochemistry in human immunodeficiency virus and zidovudine-associated myopathies.
    Pezeshkpour G; Illa I; Dalakas MC
    Hum Pathol; 1991 Dec; 22(12):1281-8. PubMed ID: 1748434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme histochemical study of germanium dioxide-induced mitochondrial myopathy in rats.
    Yim SY; Lee IY; Kim TS
    Yonsei Med J; 1999 Feb; 40(1):69-75. PubMed ID: 10198609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characterization of mitochondrial myopathies through the evaluation of the enzymatic activities involved in energy metabolism].
    Pedroso FC; Campello AP; Werneck LC; Klüppel ML
    Arq Neuropsiquiatr; 1997 Jun; 55(2):249-57. PubMed ID: 9629385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage.
    Dalakas MC; Leon-Monzon ME; Bernardini I; Gahl WA; Jay CA
    Ann Neurol; 1994 Apr; 35(4):482-7. PubMed ID: 8154877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AZT causes tissue-specific inhibition of mitochondrial bioenergetic function.
    Modica-Napolitano JS
    Biochem Biophys Res Commun; 1993 Jul; 194(1):170-7. PubMed ID: 8101441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial myopathy associated with chronic zidovudine therapy in AIDS.
    Peters BS; Winer J; Landon DN; Stotter A; Pinching AJ
    Q J Med; 1993 Jan; 86(1):5-15. PubMed ID: 8438050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histochemical, ultrastructural and biochemical study of muscle mitochondria in Leber's hereditary optic atrophy.
    Federico A; Manneschi L; Meloni M; Alessandrini C; Bardelli AM; Dotti MT; Sabatelli P
    J Inherit Metab Dis; 1988; 11 Suppl 2():193-7. PubMed ID: 2846962
    [No Abstract]   [Full Text] [Related]  

  • 19. Mitochondrial development during myogenesis.
    Vertel BM; Fischman DA
    Dev Biol; 1977 Jul; 58(2):356-71. PubMed ID: 195853
    [No Abstract]   [Full Text] [Related]  

  • 20. Fetal mitochondrial heart and skeletal muscle damage in Erythrocebus patas monkeys exposed in utero to 3'-azido-3'-deoxythymidine.
    Gerschenson M; Erhart SW; Paik CY; St Claire MC; Nagashima K; Skopets B; Harbaugh SW; Harbaugh JW; Quan W; Poirier MC
    AIDS Res Hum Retroviruses; 2000 May; 16(7):635-44. PubMed ID: 10791874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.